Kids

• Adrian Butler Elected to PRA Group Board of Directors

  

  The chief technology officer at Foot Locker,Butler brings more than 25 years of leadership experience across all areas of technology to the Board

  12-18

  Details

• The International Innovation Awards 2024 Honors Dhanarak Asset Development Co., Ltd.'s GovComplex Application

  

  KUALA LUMPUR,Malaysia,Dec. 10,2024-- TheGovComplex Application,developed by Dhanarak Asset Development (DAD),has been recognized under the Service and Solution category at the International Innovation

  12-11

  Details

• JULO Becomes First Fintech in Indonesia to Guarantee Instant 10-Minutes Disbursement

  

  JAKARTA,Indonesia,Dec. 10,2024-- JULO,Indonesia\'s leading fintech offering Virtual Credit Card features,has just raised the bar in digital financial services by launching a first-of-its-kind guarante

  12-11

  Details

• Stellantis and CATL to Invest Up to €4.1 Billion in Joint Venture for Large-Scale LFP Battery Plant in Spain

  

  Joint venture to build an all-new lithium iron phosphate (LFP) battery plant at Stellantis\' Zaragoza,Spain site

  12-11

  Details

• From Swipes to Connections: Cake Meet Simplifies Professional Networking

  

  HO CHI MINH CITY,Vietnam,Dec. 10,2024-- Cake Meet,developed by Cake,a Taiwan-originated Global Talent Platform with over 7M users,is revolutionizing professional networking across Asia.

  12-11

  Details

• Arcfra Partner Day 2024 Successfully Held in Seoul

  

  SEOUL,South Korea,Dec. 10,2024-- Arcfra Pte. Ltd. (hereinafter referred to as "Arcfra," arcfra.com),a leading innovator in cloud infrastructure and full-stack solutions,hosted its first even

  12-11

  Details

• Clarifai and Getty Images Announce Strategic Engagement to Make AI-Generated Images Available to Clarifai Customers

  

  Agreement Ensures AI-Generated Images Are Responsibly Sourced,Legally Protected,and Safe for Commercial Use

  12-11

  Details

• Live from ASH 2024 | 1.5-Year Follow-Up Data from a Global Study of Olverembatinib Reaffirms Potential in Overcoming Resistance/Intolerance to Ponatinib or Asciminib

  

  ROCKVILLE,Md. and SUZHOU,China,Dec. 10,2024-- Ascentage Pharma (6855.HK),a global biopharmaceutical company engaged in discovering,developing,and commercializing therapies to address global unmet med

  12-11

  Details

• Live from ASH 2024 | First Dataset of Olverembatinib as Second-Line Therapy in Patients with Non-T315I-Mutant CP-CML Presented in Oral Report

  

  ROCKVILLE,Md. and SUZHOU,China,Dec. 10,2024--Ascentage Pharma (6855.HK),a global biopharmaceutical company engaged in discovering,developing,and commercializing therapies to address global unmet medi

  12-11

  Details

• 【2024 ASH】TransThera Announces the Phase I Study Results of TT-01488, a Novel Non-Covalent BTK Inhibitor, in Patients with Relapsed or Refractory B-cell Malignancies

  

  NANJING,China and GAITHERSBURG,Md.,Dec. 10,2024--TransThera Sciences (Nanjing),Inc. (the "TransThera"),a clinical demand-oriented,registrational clinical stage biopharmaceutical company focu

  12-11

  Details